Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3067594rdf:typepubmed:Citationlld:pubmed
pubmed-article:3067594lifeskim:mentionsumls-concept:C1801960lld:lifeskim
pubmed-article:3067594lifeskim:mentionsumls-concept:C0022890lld:lifeskim
pubmed-article:3067594lifeskim:mentionsumls-concept:C1516635lld:lifeskim
pubmed-article:3067594pubmed:issue6lld:pubmed
pubmed-article:3067594pubmed:dateCreated1989-3-31lld:pubmed
pubmed-article:3067594pubmed:abstractTextA multitude of general disorders of the vascular system may also affect the blood circulation of the cochlea and cause symptoms such as fluctuating or permanent hearing loss. Such is the case for arteriosclerosis combined with hypertension or hypotension, collagenosis, and diabetes. Blood disorders, like leukemia, sickle cell anemia, and polycythemia, and infectious diseases involving the blood vessels, such as lues, may also present their primary symptoms in the ear. The otorhinolaryngologist must be able to establish the correct diagnosis and refer patients requiring more general treatment to other specialists. The use of specific vasoactive treatment should be continued to those patients with symptoms of acute or fluctuating hearing loss, vertigo, or tinnitus who exhibit no other signs. Modern techniques for cochlear blood flow measurements have verified that several of the treatment protocols in use, which have a sound theoretical background, do indeed increase cochlear blood flow.lld:pubmed
pubmed-article:3067594pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3067594pubmed:languageenglld:pubmed
pubmed-article:3067594pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3067594pubmed:citationSubsetIMlld:pubmed
pubmed-article:3067594pubmed:statusMEDLINElld:pubmed
pubmed-article:3067594pubmed:issn0196-0709lld:pubmed
pubmed-article:3067594pubmed:authorpubmed-author:HultcrantzEElld:pubmed
pubmed-article:3067594pubmed:issnTypePrintlld:pubmed
pubmed-article:3067594pubmed:volume9lld:pubmed
pubmed-article:3067594pubmed:ownerNLMlld:pubmed
pubmed-article:3067594pubmed:authorsCompleteYlld:pubmed
pubmed-article:3067594pubmed:pagination317-22lld:pubmed
pubmed-article:3067594pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:3067594pubmed:meshHeadingpubmed-meshheading:3067594-...lld:pubmed
pubmed-article:3067594pubmed:meshHeadingpubmed-meshheading:3067594-...lld:pubmed
pubmed-article:3067594pubmed:meshHeadingpubmed-meshheading:3067594-...lld:pubmed
pubmed-article:3067594pubmed:meshHeadingpubmed-meshheading:3067594-...lld:pubmed
pubmed-article:3067594pubmed:meshHeadingpubmed-meshheading:3067594-...lld:pubmed
pubmed-article:3067594pubmed:meshHeadingpubmed-meshheading:3067594-...lld:pubmed
pubmed-article:3067594pubmed:articleTitleClinical treatment of vascular inner ear diseases.lld:pubmed
pubmed-article:3067594pubmed:affiliationDepartment of Otorhinolaryngology, University of Uppsala, Sweden.lld:pubmed
pubmed-article:3067594pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3067594pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:3067594pubmed:publicationTypeReviewlld:pubmed
pubmed-article:3067594pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3067594lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3067594lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3067594lld:pubmed